The potential impact of expanding antiretroviral therapy and combination prevention in Vietnam: Towards elimination of HIV transmission

Journal of Acquired Immune Deficiency Syndromes

Volumn 63, Issue 5, 2013, Pages

  Kato, Masaya ^a   Granich, Reuben ^a   Bui, Duong D ^b   Tran, Hoang V ^c   Nadol, Patrick ^d   Jacka, David ^a   Sabin, Keith ^a   Suthar, Amitabh B ^a   Mesquita, Fabio ^a   Lo, Ying Ru ^a   Williams, Brian ^e  

^a WORLD HEALTH ORGANIZATION   (Switzerland)

^b MINISTRY OF HEALTH   (Viet Nam)

^c PARTNERS IN HEALTH   (United States)

^d US Center for Disease Prevention and Control Vietnam Country Office   (Viet Nam)

^e STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Antiretroviral therapy; Elimination; HIV transmission; People who inject drugs; Prevention; Vietnam

Indexed keywords

METHADONE;

ANTIVIRAL THERAPY; ARTICLE; CONDOM USE; COST CONTROL; COST EFFECTIVENESS ANALYSIS; DISEASE TRANSMISSION; EARLY INTERVENTION; EPIDEMIC; HIV TEST; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; MATHEMATICAL MODEL; METHADONE TREATMENT; PRIORITY JOURNAL; TREATMENT PLANNING; VIET NAM; VIRUS TRANSMISSION;

ADULT; ANTI-RETROVIRAL AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COST-BENEFIT ANALYSIS; COUNSELING; DISEASE TRANSMISSION, INFECTIOUS; EARLY DIAGNOSIS; FEMALE; HIV INFECTIONS; HUMANS; MALE; MODELS, THEORETICAL; PREVALENCE; VIETNAM;

EID: 84883458797     PISSN: 15254135     EISSN: 10779450     Source Type: Journal    
DOI: 10.1097/QAI.0b013e31829b535b     Document Type: Article

References (51)

1. Quinn TC, Wawer MJ, Sewankambo N, et al. Viral load and heterosexual transmission of human immunodeficiency virus type 1. Rakai Project Study Group. N Engl J Med. 2000;342:921-929.
2. CDC. Achievements in public health. Reduction in perinatal transmission of HIV infection-United States, 1985-2005. MMWR Morb Mortal Wkly Rep. 2006;55:592-597.
3. Attia S, Egger M, Muller M, et al. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and metaanalysis. AIDS. 2009;23:1397-1404.
4. Anglemyer A, Rutherford GW, Baggaley RC, et al. Antiretroviral therapy for prevention of HIV transmission in HIV-discordant couples. Cochrane Database Syst Rev. 2011;10:CD009153.
5. Cohen MS, Chen YQ, McCauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;365:493-505.
6. Fang CT, Hsu HM, Twu SJ, et al. Decreased HIV transmission after a policy of providing free access to highly active antiretroviral therapy in Taiwan. J Infect Dis. 2004;190:879-885.
7. Das M, Chu PL, Santos GM, et al. Decreases in community viral load are accompanied by reductions in new HIV infections in San Francisco. PLoS One. 2010;5:e11068.
8. Montaner JS, Lima VD, Barrios R, et al. Association of highly active antiretroviral therapy coverage, population viral load, and yearly new HIV diagnoses in British Columbia, Canada: a population-based study. Lancet. 2010;376:532-539.
9. Tanser F, Barnighausen T, Grapsa E, et al. High coverage of ART associated with decline in risk of HIV acquisition in rural KwaZulu-Natal, South Africa. Science. 2013;339:966-971.
10. Wood E, Kerr T, Marshall BD, et al. Longitudinal community plasma HIV-1 RNA concentrations and incidence of HIV-1 among injecting drug users: prospective cohort study. BMJ. 2009;338:b1649.
11. Eaton JW, Johnson LF, Salomon JA, et al. HIV Treatment as Prevention: systematic comparison of mathematical models of the potential impact of antiretroviral therapy on HIV incidence in South Africa. PLoS Med. 2012;9:e1001245.
12. Granich RM, Gilks CF, Dye C, et al. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet. 2009;373:48-57.
13. Alistar SS, Owens DK, Brandeau ML. Effectiveness and cost effectiveness of expanding harm reduction and antiretroviral therapy in a mixed HIV epidemic: a modeling analysis for Ukraine. PLoS Med. 2011;8:e1000423.
14. Degenhardt L, Mathers B, Vickerman P, et al. Prevention of HIV infection for people who inject drugs: why individual, structural, and combination approaches are needed. Lancet. 2010;376:285-301.
15. Strathdee SA, Hallett TB, Bobrova N, et al. HIV and risk environment for injecting drug users: the past, present, and future. Lancet. 2010;376: 268-284.
16. Li J, Gilmour S, Zhang H, et al. The epidemiological impact and costeffectiveness of HIV testing, antiretroviral treatment and harm reduction programs. AIDS. 2012;26:2069-2078.
17. Granich R, Gupta S, Suthar AB, et al. Antiretroviral therapy in prevention of HIV and TB: update on current research efforts. Curr HIV Res. 2011;9:446-469.
18. UNAIDS. UNAIDS Report on the Global AIDS Epidemic 2010. Geneva, Switzerland: UNAIDS; 2010.
19. Viet Nam AIDS Response Progress Report 2012. Hanoi, Vietnam: National Committee for AIDS, Drugs and prostitution prevention and control; 2012. http://www.unaids.org/en/dataanalysis/knowyourresponse/countryprogressreports/ 2012countries/ce-VN-Narrative-Report.pdf (Accessed on 2 March 2013).
20. WHO. The Strategic Use of Antiretrovirals to Help End the HIV Epidemic. Geneva, Switzerland: World Health Organization; 2012.
21. WHO. Programmatic Update: Antiretroviral Treatment as Prevention (TasP) of HIV and TB. Geneva, Switzerland: World Health Organization; 2012.
22. Hirnschall G, Schwartlander B. Treatment 2.0: catalysing the next phase of scale-up. Lancet. 2011; 378:209-11.
23. Bui DD, Mesquita F, Do TN, et al. Treatment 2.0 Pilot in Viet Nam - early progress and challenges. World J AIDS. 2012;2:64-70.
24. Williams BG, Granich R, De Cock KM, et al. Antiretroviral therapy for tuberculosis control in nine African countries. Proc Natl Acad Sci U S A. 2010;107:19485-19489.
25. Williams BG, Granich R, Dye C. Role of acute infection in HIV transmission. Lancet. 2011;378:1913; author reply 1914-1915.
26. Viet Nam HIV/AIDS Estimates and Projections 2007-2012. Hanoi, Viet Nam: Viet Nam Authority of HIV/AIDS Control, Ministry of Health; 2009.
27. Viet Nam HIV/AIDS Estimates and Projections 2011-2015. Hanoi, Viet Nam: Viet Nam Authority of HIV/AIDS Control, Ministry of Health; 2012.
28. Results from the HIV/STI Integrated Biolgoical and Behavioral Surveillance (IBBS) in Viet Nam 2005-2006. Hanoi, Viet Nam: Ministry of Health - Viet Nam; 2006.
29. Results from the HIV/STI Integrated Biological and Behavioral Surveillance (IBBS) in Viet Nam - Round II 2009. Ministry of Health - Viet Nam. Hanoi, Viet Nam. 2011.
30. Granich R, Kahn JG, Bennett R, et al. Expanding ART for treatment and prevention of HIV in South Africa: estimated cost and cost-effectiveness 2011-2050. PLoS One. 2012;7:e30216.
31. Travis L, Tran TD, Tran HM. Triangulation Exercise on Intimate Partner Transmission of HIV in Viet Nam. Hanoi, Viet Nam: UNAIDS and UN Women; 2012.
32. Baseline Surveys in Female Sexual Partners of Male IDUs in Dien Bien and Ho Chi Minh City. Hanoi, Viet Nam: Partners in Health Research; 2012.
33. Merson MH, O'Malley J, Serwadda D, et al. The history and challenge of HIV prevention. Lancet. 2008;372:475-488.
34. WHO. Good Practice in Asia: Targeted HIV Prevention for IDU and Sex Workers. Viet nam's First Large-Scale National Arm Reduction Initiative WHO/WPRO and Partners. Hanoi, Vietnam: World Health Organization; 2010. http://www.who.int/hiv/pub/idu/wpro-vietnam/en/ Accessed on 2 March 2013.
35. Malta M, Magnanini MM, Strathdee SA, et al. Adherence to antiretroviral therapy among HIV-infected drug users: a meta-analysis. AIDS Behav. 2010;14:731-747.
36. Wood E, Kerr T, Tyndall MW, et al. A review of barriers and facilitators of HIV treatment among injection drug users. AIDS. 2008;22: 1247-1256.
37. Baggaley RF, Boily MC, White RG, et al. Risk of HIV-1 transmission for parenteral exposure and blood transfusion: a systematic review and meta-analysis. AIDS. 2006;20:805-812.
38. Hudgens MG, Longini IM Jr, Halloran ME, et al. Estimating the transmission probability of human immunodeficiency virus in injecting drug users in Thailand. Appl Stat. 2001;50:1-14.
39. Royce RA, Sena A, Cates W Jr, et al. Sexual transmission of HIV. N Engl J Med. 1997;336:1072-1078.
40. Cohen MS, Dye C, Fraser C, et al. HIV treatment as prevention: debate and commentary - will early infection compromise treatment-as-prevention strategies? PLoS Med. 2012;9:e1001232.
41. Milloy MJ, Montaner J, Wood E. Barriers to HIV treatment among people who use injection drugs: implications for 'treatment as prevention'. Curr Opin HIV AIDS. 2012;7:332-338.
42. Maher L, Coupland H, Musson R. Scaling up HIV treatment, care and support for injecting drug users in Vietnam. Int J Drug Policy. 2007;18: 296-305.
43. WHO. Assessment of Compulsory Treatment of People Who Use Drugs in Cambodia, China, Malaysia and Viet Nam: An Application of Selected Human Rights Principles. Manila, Philippines: World Health Organization Western Pacific Regional Office; 2009.
44. UN Joint Statement. Compulsory drug detention and rehabilitation centres. 2012. Available at: http://www.unodc.org/documents/eastasiaandpacific//2012/03/ drug-detention-centre/JC2310-Joint-Statement6March12FINAL-En.pdf. (Accessed on 2 March 2013).
45. Behavioral Survey of Male Clients of Female Sex Workers Across Seven Provinces in Viet Nam. Hanoi, Viet Nam: Population Service International Viet Nam; 2009.
46. Gowing L, Farrell MF, Bornemann R, et al. Oral substitution treatment of injecting opioid users for prevention of HIV infection. Cochrane Database Syst Rev. 2011:CD004145.
47. Evaluation of the Pilot Model for the Substitution Treatment of Opiate Dependence Using Methadone in Hai Phong and Ho Chi Minh City (Phase 1). Hanoi, Viet Nam: Viet Nam Ministry of Health; 2009.
48. Weller S, Davis K. Condom effectiveness in reducing heterosexual HIV transmission. Cochrane Database Syst Rev. 2002:CD003255.
49. WHO. Prevention and Treatment of HIV and Other Sexually Transmitted Infections Among Men Who Have Sex With Men and Transgender People: Recommendations for a Public Health Approach 2011-Annexes. Geneva, Switzerland: World Health Organization;2011.
50. Duong AT, Kato M, Bales S, et al. Costing analysis of national HIV treatment and care programme in Vietnam. JAIDS 2013 [Epub ahead of print].
51. Cost analyses of selected USAID-supported HIV interventions managed by FHI 360 in Vietnam: outreach, HIV testing and counseling (HTC), and anti-retroviral treatment (ART) 2009-2010. FHI 360/Urban Care. Hanoi, Vietnam. 2012.